Biondi Paul 4
4 · Seres Therapeutics, Inc. · Filed Mar 23, 2020
Insider Transaction Report
Form 4
Biondi Paul
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-03-20+30,000→ 30,000 totalExercise: $3.10Exp: 2030-03-19→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option will vest in four equal installments on each anniversary of March 20, 2020 or in full immediately prior to the occurrence of a change in control.